Using Modern Imaging Technology

Learn More

With new, proprietary drug formulations

Learn More

To precisely treat late stage and metastatic cancer

Learn More

and to stimulate a natural, adaptive immune response.

Learn More

Intensity Therapeutics is creating a new, highly effective cancer treatment - in situ vaccination.

Learn More

Intensity Therapeutics is a Qualified Connecticut Business

Intensity Therapeutics' is a "Qualified Connecticut Business" (QCB) as approved by CT Innovations. The State of Connecticut launched a program in 2010 that allows Angels providing capital to QCBs to take a credit against Connecticut State income tax for certain investments made in qualifying businesses. Investments must be at least $25,000 in order to be considered under the Program and the income tax credit equals 25% of the cash investment up to a maximum credit of $250,000.


Intensity Therapeutics is a development stage company that has conducted proof-of-concept in vivo experiments using its novel in situ vaccination technology. The Company is interested in collaborating with pharmaceutical, imaging or biotechnology companies interested in developing the new approach to treating cancer.   


Please contact Lew Bender via email at or call our office at (203) 682-2434 or Lew's cell number at (914) 329-6571

Contact Us

Intensity Therapeutics, Inc.
8 Wright Street, Suite 107
Westport, CT 06880

Tel. (203) 682-2434
Fax (203) 664-1051


Click here for career inquiries

Who we are

Intensity Therapeutics is a product development stage company. We are seeking partnerships/investors interested in advancing the company’s anti-cancer platform technology and lead product INT230-6.


Click here for inquiries


Case number 01930099